Name: Allergy Treatment Market Size, Competitive Landscape and Market Forecast - 2029
Brand: DataM Intelligence
SKU: DMPH1497
Price: 4350 USD
Availability: InStock

Allergy Treatment Market Size Share Growth Opportunities and Forecast 2022

Allergy Treatment Market Size, Competitive Landscape and Market Forecast - 2029

<h2>Global Allergy Treatment Market is segmented&nbsp;by&nbsp;Allergy Type (Eye Allergy, Food Allergy, Skin Allergy, Asthma, Rhinitis, and Others), By Treatment Type(Anti-Allergy Drugs (Antihistamines, Corticosteroids, Leukotriene Inhibitors, Others), Immunotherapy (Subcutaneous Immunotherapy, Sublingual Immunotherapy)),&nbsp;and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2022-2029</h2>

<h2>&nbsp;</h2>

<h2>Market Overview</h2>

<blockquote>
The Allergy Treatment Market is expected to grow at a <a href="https://www.datamintelligence.com/download-sample/allergy-treatment-market">CAGR of 4.8%</a> during the forecasting period (2022-2029).
</blockquote>

<h3>Trending Topics</h3>

<a href="https://www.datamintelligence.com/research-report/allergy-immunotherapies-market">Allergy Immunotherapies Market</a>

<a href="https://www.datamintelligence.com/research-report/allergy-diagnostics-market">Allergy Diagnostics Market</a>

<a href="https://www.datamintelligence.com/research-report/latex-allergy-market">Latex Allergy Market</a>

<h2>&nbsp;</h2>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px"><big>Table of Contents</big></h2>

<ol>
	<li>
	Methodology and Scope

	<ol>
		<li>
		Research Methodology
		</li>
		<li>
		Research Objective and Scope of the Report
		</li>
	</ol>
	</li>
	<li>
	Market Definition and Overview
	</li>
	<li>
	Executive Summary

	<ol>
		<li>
		Market Snippet by Allergy Type
		</li>
		<li>
		Market Snippet by Treatment Type
		</li>
		<li>
		Market Snippet by Region
		</li>
	</ol>
	</li>
	<li>
	Market Dynamics

	<ol>
		<li>
		Market Impacting Factors

		<ol>
			<li>
			Drivers

			<ol>
				<li>
				Growing prevalence of chronic disorders
				</li>
				<li>
				Technological Advancements
				</li>
			</ol>
			</li>
			<li>
			Restraints
			</li>
			<li>
			Opportunity
			</li>
			<li>
			Impact Analysis
			</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	Industry Analysis&nbsp;

	<ol>
		<li>
		Porter&#39;s Five Forces Analysis&nbsp;
		</li>
		<li>
		Epidemiology
		</li>
		<li>
		Pipeline Analysis
		</li>
	</ol>
	</li>
	<li>
	By Allergy Type

	<ol>
		<li>
		&nbsp;Introduction&nbsp;

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Allergy Type
			</li>
			<li>
			Market Attractiveness Index, By Allergy Type
			</li>
		</ol>
		</li>
		<li>
		Eye Allergy

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2028
			</li>
		</ol>
		</li>
		<li>
		Asthma
		</li>
		<li>
		Skin Allergy
		</li>
		<li>
		Rhinitis
		</li>
		<li>
		Food Allergy
		</li>
		<li>
		Others
		</li>
	</ol>
	</li>
	<li>
	By Treatment Type

	<ol>
		<li>
		&nbsp;Introduction&nbsp;

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
			</li>
			<li>
			Market Attractiveness Index, By Treatment Type
			</li>
		</ol>
		</li>
		<li>
		Anti-allergy Drugs

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2028

			<ol>
				<li>
				Antihistamines
				</li>
				<li>
				Corticosteroids
				</li>
				<li>
				Leukotriene Inhibitors
				</li>
				<li>
				Others
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Immunotherapy

		<ol>
			<li>
			Subcutaneous Immunotherapy
			</li>
			<li>
			Sublingual Immunotherapy
			</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	By Region

	<ol>
		<li>
		Introduction&nbsp;

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
			</li>
			<li>
			Market Attractiveness Index, By Region
			</li>
		</ol>
		</li>
		<li>
		North America

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Allergy Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				The U.S.
				</li>
				<li>
				Canada
				</li>
				<li>
				Mexico
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Europe

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Allergy Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				Germany
				</li>
				<li>
				The U.K.
				</li>
				<li>
				France
				</li>
				<li>
				Italy
				</li>
				<li>
				Spain
				</li>
				<li>
				Rest of Europe
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		South America

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Allergy Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				Brazil
				</li>
				<li>
				Argentina
				</li>
				<li>
				Rest of South America
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Asia Pacific

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Allergy Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				China
				</li>
				<li>
				India
				</li>
				<li>
				Japan
				</li>
				<li>
				Australia
				</li>
				<li>
				Rest of Asia Pacific
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Middle East &amp; Africa

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Allergy Type
			</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	Competitive Landscape

	<ol>
		<li>
		Competitive Scenario
		</li>
		<li>
		Competitor&nbsp; Allergy Treatment Strategy Analysis
		</li>
		<li>
		Comparative Allergy Type Portfolio Analysis
		</li>
		<li>
		Market Positioning/Share Analysis
		</li>
		<li>
		Mergers and Acquisitions Analysis
		</li>
	</ol>
	</li>
	<li>
	Company Profiles

	<ol>
		<li>
		GlaxoSmithKline

		<ol>
			<li>
			Company Overview
			</li>
			<li>
			Allergy Type Portfolio and Description
			</li>
			<li>
			Key Highlights
			</li>
			<li>
			Financial Overview
			</li>
		</ol>
		</li>
		<li>
		Teva Pharmaceuticals
		</li>
		<li>
		&nbsp;Sallergenes Greer
		</li>
		<li>
		&nbsp;Allergy Therapeutics
		</li>
		<li>
		&nbsp;Sanofi SA
		</li>
		<li>
		&nbsp;Sunovion Pharmaceuticals Inc.
		</li>
		<li>
		&nbsp;Johnson &amp; Johnson
		</li>
		<li>
		&nbsp;Merck KGaA
		</li>
		<li>
		&nbsp;F. Hoffmann-La Roche AG
		</li>
		<li>
		&nbsp;Allergan plc
		</li>
	</ol>
	</li>
	<li>
	DataM Intelligence&nbsp;

	<ol>
		<li>
		Appendix
		</li>
		<li>
		About Us and Services
		</li>
		<li>
		Contact Us
		</li>
	</ol>
	</li>
</ol>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px"><big>List of Tables &amp; Figures</big></h2>

List of Tables

TABLE 01.&nbsp; GLOBAL ALLERGY TREATMENT MARKET VALUE, 2021, 2025 &amp; 2029, BY ALLERGY TYPE, ($MILLION)

TABLE 02.&nbsp; GLOBAL ALLERGY TREATMENT MARKET VALUE 2021, 2025 &amp; 2029, BY TREATMENT TYPE, ($MILLION)

TABLE 04.&nbsp; GLOBAL ALLERGY TREATMENT MARKET VALUE 2021, 2025 &amp; 2029, BY REGION, ($MILLION)

TABLE 05.&nbsp; GLOBAL ALLERGY TREATMENT MARKET SHARE 2021, 2025 &amp; 2029 (%), BY ALLERGY TYPE ($MILLION)

TABLE 06.&nbsp; GLOBAL ALLERGY TREATMENT MARKET VALUE, BY ALLERGY TYPE, 2018&ndash;2029 ($MILLION)

TABLE 07.&nbsp; GLOBAL ALLERGY TREATMENT MARKET SHARE 2021, 2025 &amp; 2029 (%), BY TREATMENT TYPE ($MILLION)

TABLE 08.&nbsp; GLOBAL ALLERGY TREATMENT MARKET VALUE, BY TREATMENT TYPE, 2018&ndash;2029 ($MILLION)

TABLE 11.&nbsp; GLOBAL ALLERGY TREATMENT MARKET SHARE 2021, 2025 &amp; 2029 (%), BY REGION ($MILLION)

TABLE 12.&nbsp; GLOBAL ALLERGY TREATMENT MARKET VALUE, BY REGION, 2018&ndash;2029 ($MILLION)

TABLE 13.&nbsp; NORTH AMERICA ALLERGY TREATMENT MARKET VALUE, BY ALLERGY TYPE, 2018&ndash;2029 ($MILLION)

TABLE 14.&nbsp; NORTH AMERICA ALLERGY TREATMENT MARKET VALUE, BY TREATMENT TYPE, 2018&ndash;2029 ($MILLION)

TABLE 16.&nbsp; NORTH AMERICA ALLERGY TREATMENT MARKET VALUE, BY COUNTRY, 2018&ndash;2029 ($MILLION)

TABLE 17.&nbsp; SOUTH AMERICA ALLERGY TREATMENT MARKET VALUE, BY ALLERGY TYPE, 2018&ndash;2029 ($MILLION)

TABLE 18.&nbsp; SOUTH AMERICA ALLERGY TREATMENT MARKET VALUE, BY TREATMENT TYPE, 2018&ndash;2029 ($MILLION)

TABLE 20.&nbsp; SOUTH AMERICA ALLERGY TREATMENT MARKET VALUE, BY COUNTRY, 2018&ndash;2029 ($MILLION)

TABLE 21.&nbsp; EUROPE ALLERGY TREATMENT MARKET VALUE, BY ALLERGY TYPE, 2018&ndash;2029 ($MILLION)

TABLE 22.&nbsp; EUROPE ALLERGY TREATMENT MARKET VALUE, BY TREATMENT TYPE, 2018&ndash;2029 ($MILLION)

TABLE 24.&nbsp; EUROPE ALLERGY TREATMENT MARKET VALUE, BY COUNTRY, 2018&ndash;2029 ($MILLION)

TABLE 25.&nbsp; ASIA PACIFIC ALLERGY TREATMENT MARKET VALUE, BY ALLERGY TYPE, 2018&ndash;2029 ($MILLION)

TABLE 26.&nbsp; ASIA PACIFIC ALLERGY TREATMENT MARKET VALUE, BY TREATMENT TYPE, 2018&ndash;2029 ($MILLION)

TABLE 28.&nbsp; ASIA PACIFIC ALLERGY TREATMENT MARKET VALUE, BY COUNTRY, 2018&ndash;2029 ($MILLION)

TABLE 29.&nbsp; MIDDLE EAST &amp; AFRICA ALLERGY TREATMENT MARKET VALUE, BY ALLERGY TYPE, 2018&ndash;2029 ($MILLION)

TABLE 30.&nbsp; MIDDLE EAST &amp; AFRICA ALLERGY TREATMENT MARKET VALUE, BY TREATMENT TYPE, 2018&ndash;2029 ($MILLION)

TABLE 32.&nbsp; GLAXOSMITHKLINE.: OVERVIEW

TABLE 33.&nbsp; GLAXOSMITHKLINE.: ALLERGY TYPE PORTFOLIO

TABLE 34.&nbsp; GLAXOSMITHKLINE.: KEY DEVELOPMENTS

TABLE 35.&nbsp; TEVA PHARMACEUTICALS: OVERVIEW

TABLE 36.&nbsp; TEVA PHARMACEUTICALS: ALLERGY TYPE PORTFOLIO

TABLE 37.&nbsp; TEVA PHARMACEUTICALS: KEY DEVELOPMENTS

TABLE 38.&nbsp; SALLERGENES GREER: OVERVIEW

TABLE 39.&nbsp; SALLERGENES GREER: ALLERGY TYPE PORTFOLIO

TABLE 40.&nbsp; SALLERGENES GREER: KEY DEVELOPMENTS

TABLE 41.&nbsp; ALLERGY THERAPEUTICS: OVERVIEW

TABLE 42.&nbsp; ALLERGY THERAPEUTICS: ALLERGY TYPE PORTFOLIO

TABLE 43.&nbsp; ALLERGY THERAPEUTICS: KEY DEVELOPMENTS

TABLE 44.&nbsp; SANOFI SA.: OVERVIEW

TABLE 45.&nbsp; SANOFI SA.: ALLERGY TYPE PORTFOLIO

TABLE 46.&nbsp; SANOFI SA.: KEY DEVELOPMENTS

TABLE 47.&nbsp; SUNOVION PHARMACEUTICALS INC: OVERVIEW

TABLE 48.&nbsp; SUNOVION PHARMACEUTICALS INC: ALLERGY TYPE PORTFOLIO

TABLE 49.&nbsp; SUNOVION PHARMACEUTICALS INC: KEY DEVELOPMENTS

TABLE 50.&nbsp; JOHNSON &amp; JOHNSON.: OVERVIEW

TABLE 51.&nbsp; JOHNSON &amp; JOHNSON.: ALLERGY TYPE PORTFOLIO

TABLE 52.&nbsp; JOHNSON &amp; JOHNSON.: KG: KEY DEVELOPMENTS

TABLE 53.&nbsp; MERCK KGAA.: OVERVIEW

TABLE 54.&nbsp; MERCK KGAA.: ALLERGY TYPE PORTFOLIO

TABLE 55.&nbsp; MERCK KGAA.: KEY DEVELOPMENTS

TABLE 56.&nbsp; F. HOFFMANN-LA ROCHE AG: OVERVIEW

TABLE 57.&nbsp; F. HOFFMANN-LA ROCHE AG: ALLERGY TYPE PORTFOLIO

TABLE 58.&nbsp; F. HOFFMANN-LA ROCHE AG: KEY DEVELOPMENTS

TABLE 59.&nbsp; ALLERGAN PLC: OVERVIEW

TABLE 60.&nbsp; ALLERGAN PLC: ALLERGY TYPE PORTFOLIO

TABLE 61.&nbsp; ALLERGAN PLC: KEY DEVELOPMENTS

LIST OF FIGURES

FIGURE 01.&nbsp; GLOBAL ALLERGY TREATMENT MARKET SHARE, 2018 &amp; 2029 (%), BY ALLERGY TYPE

FIGURE 02.&nbsp; GLOBAL ALLERGY TREATMENT MARKET SHARE, 2018 &amp; 2029 (%), BY TREATMENT TYPE

FIGURE 04.&nbsp; GLOBAL ALLERGY TREATMENT MARKET SHARE, 2018 &amp; 2029 (%), BY REGION

FIGURE 05.&nbsp; GLOBAL ALLERGY TREATMENT MARKET VALUE, 2018 - 2029 AND YEAR ON YEAR GROWTH

FIGURE 06.&nbsp; GLOBAL ALLERGY TREATMENT MARKET YEAR ON YEAR GROWTH 2018 TO 2029 (%), BY ALLERGY TYPE&nbsp;

FIGURE 07&nbsp; &nbsp;GLOBAL ALLERGY TREATMENT MARKET VALUE, BY RHINITIS, 2018&ndash;2029 ($MILLION)

FIGURE 08&nbsp; &nbsp;GLOBAL ALLERGY TREATMENT MARKET VALUE, BY SKIN ALLERGY, 2018&ndash;2029 ($MILLION)

FIGURE 09&nbsp; &nbsp;GLOBAL ALLERGY TREATMENT MARKET VALUE, BY FOOD ALLERGY, 2018&ndash;2029 ($MILLION)

FIGURE 09&nbsp; &nbsp;GLOBAL ALLERGY TREATMENT MARKET VALUE, BY EYE ALLERGY, 2018&ndash;2029 ($MILLION)

FIGURE 09&nbsp; &nbsp;GLOBAL ALLERGY TREATMENT MARKET VALUE, BY ASTHMA, 2018&ndash;2029 ($MILLION)

FIGURE 09&nbsp; &nbsp;GLOBAL ALLERGY TREATMENT MARKET VALUE, BY OTHERS, 2018&ndash;2029 ($MILLION)

FIGURE 14&nbsp; &nbsp;GLOBAL ALLERGY TREATMENT MARKET YEAR ON YEAR GROWTH 2018 TO 2029 (%), BY TREATMENT TYPE

FIGURE 15&nbsp; &nbsp;GLOBAL ALLERGY TREATMENT MARKET VALUE, BY ANTI-ALLERGY DRUGS, 2018&ndash;2029 ($MILLION)

FIGURE 16&nbsp; &nbsp;GLOBAL ALLERGY TREATMENT MARKET VALUE, BY IMMUNOTHERAPY, 2018&ndash;2029 ($MILLION)

FIGURE 18&nbsp; GLOBAL ALLERGY TREATMENT MARKET YEAR ON YEAR GROWTH 2018 TO 2029 (%), BY REGION

FIGURE 19&nbsp; &nbsp;NORTH AMERICA ALLERGY TREATMENT MARKET VALUE, 2018&ndash;2029 ($MILLION)

FIGURE 20&nbsp; &nbsp;NORTH AMERICA ALLERGY TREATMENT MARKET SHARE (%), BY ALLERGY TYPE, 2018&ndash;2029 ($MILLION)

FIGURE 21&nbsp; &nbsp;NORTH AMERICA ALLERGY TREATMENT MARKET SHARE (%), BY TREATMENT TYPE, 2018&ndash;2029 ($MILLION)

FIGURE 23&nbsp; &nbsp;NORTH AMERICA ALLERGY TREATMENT MARKET SHARE (%), BY COUNTRIES, 2018&ndash;2029 ($MILLION)&nbsp;

FIGURE 24&nbsp; SOUTH AMERICA ALLERGY TREATMENT MARKET VALUE, 2018&ndash;2029 ($MILLION)

FIGURE 25&nbsp; &nbsp;SOUTH AMERICA ALLERGY TREATMENT MARKET SHARE (%), BY ALLERGY TYPE, 2018&ndash;2029 ($MILLION)

FIGURE 26&nbsp; SOUTH AMERICA ALLERGY TREATMENT MARKET SHARE (%), BY TREATMENT TYPE, 2018&ndash;2029 ($MILLION)

FIGURE 28&nbsp; &nbsp;SOUTH AMERICA ALLERGY TREATMENT MARKET SHARE (%), BY COUNTRIES, 2018&ndash;2029 ($MILLION)

FIGURE 29&nbsp; &nbsp;EUROPE ALLERGY TREATMENT MARKET VALUE, 2018&ndash;2029 ($MILLION)

FIGURE 30 EUROPE ALLERGY TREATMENT MARKET SHARE (%), BY ALLERGY TYPE, 2018&ndash;2029 ($MILLION)

FIGURE 31&nbsp; &nbsp;EUROPE ALLERGY TREATMENT MARKET SHARE (%), BY TREATMENT TYPE, 2018&ndash;2029 ($MILLION)

FIGURE 33&nbsp; EUROPE ALLERGY TREATMENT MARKET SHARE (%), BY COUNTRIES, 2018&ndash;2029 ($MILLION)

FIGURE 34&nbsp; &nbsp;ASIA PACIFIC ALLERGY TREATMENT MARKET VALUE, 2018&ndash;2029 ($MILLION)

FIGURE 35&nbsp; &nbsp;ASIA PACIFIC ALLERGY TREATMENT MARKET SHARE (%), BY ALLERGY TYPE, 2018&ndash;2029 ($MILLION)

FIGURE 36&nbsp; &nbsp;ASIA PACIFIC ALLERGY TREATMENT MARKET SHARE (%), BY TREATMENT TYPE, 2018&ndash;2029 ($MILLION)

FIGURE 38&nbsp; &nbsp;ASIA PACIFIC ALLERGY TREATMENT MARKET SHARE (%), BY COUNTRIES, 2018&ndash;2029 ($MILLION)

FIGURE 39&nbsp; MIDDLE EAST AND AFRICA ALLERGY TREATMENT MARKET VALUE, 2018&ndash;2029 ($MILLION)

FIGURE 40&nbsp; &nbsp;MIDDLE EAST AND AFRICA ALLERGY TREATMENT MARKET SHARE (%), BY ALLERGY TYPE, 2018&ndash;2029 ($MILLION)

FIGURE 41&nbsp; &nbsp;MIDDLE EAST AND AFRICA ALLERGY TREATMENT MARKET SHARE (%), BY TREATMENT TYPE, 2018&ndash;2029 ($MILLION)

FIGURE 43.&nbsp; GLAXOSMITHKLINE.: FINANCIALS

FIGURE 44.&nbsp; TEVA PHARMACEUTICALS: FINANCIALS

FIGURE 45.&nbsp; SALLERGENES GREER: FINANCIALS

FIGURE 46&nbsp; ALLERGY THERAPEUTICS: FINANCIALS

FIGURE 47.&nbsp; SANOFI SA.: FINANCIALS

FIGURE 48.&nbsp; SUNOVION PHARMACEUTICALS INC: FINANCIALS

FIGURE 49.&nbsp; &nbsp;JOHNSON &amp; JOHNSON.: FINANCIALS

FIGURE 50.&nbsp; MERCK KGAA.: FINANCIALS

FIGURE 51.&nbsp; F. HOFFMANN-LA ROCHE AG: FINANCIALS

FIGURE 52.&nbsp; ALLERGAN PLC: FINANCIALS

Allergy Treatment Market Size, Competitive Landscape and Market Forecast - 2029

Allergy Treatment Market Size, Competitive Landscape and Market Forecast - 2029

Market Overview

Trending Topics

Buy This Report